Volastra Therapeutics’ Extended $44M Seed Financing

Wilmer Cutler Pickering Hale and Dorr LLP advised Volastra Therapeutics on the deal.Volastra Therapeutics, a biotechnology company developing novel therapies for the prevention and treatment of…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now